Comment

DOI10.1080/01621459.2012.665615zbMATH Open1328.62579OpenAlexW1935711966WikidataQ36713954 ScholiaQ36713954MaRDI QIDQ4916482FDOQ4916482

Authors: Daniel Almirall, Daniel J. Lizotte, Susan A. Murphy 

Publication date: 22 April 2013

Published in: Journal of the American Statistical Association (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/01621459.2012.665615

Recommendations

• Comment
• Evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer
• Erratum
• A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics
• Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models
• Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model
• Identifying optimal adaptive therapeutic schedules for prostate cancer through combining mathematical modeling and dynamic optimization
• Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer
• Comment on ``Dynamic treatment regimes: technical challenges and applications
• Dynamic behavior of stochastic prostate cancer system with comprehensive therapy under regime switching

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Sequential statistical analysis (62L10)

Cites Work

• Title not available (Why is that?)
• Screening experiments for developing dynamic treatment regimes
• Sample size formulae for two-stage randomized trials with survival outcomes
• Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies

This page was built for publication: Comment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4916482)